CIK 0001368514
- Large accelerated filer
ADMA BIOLOGICS, INC.
Sign in to watch- Ticker
- ADMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 562590442
- Phone
- +1 201-478-5552
- Business address
- C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446
- Former names
- R&R ACQUISITION VI, INC
- 4 Open-market buy President & CEO bought 4,226 shares at an average $8.15 ($34,435)
- 4 Open-market buy President & CEO bought 874 shares at $8.07 ($7,053)
- 4 Open-market buy President & CEO bought 13,400 shares at an average $7.50 ($100,475)
- 4 Open-market buy Chief Financial Officer bought 1,000 shares at $7.50 ($7,500)
- 4 Open-market buy CSO/CMO bought 1,315 shares at $7.60 ($9,994)
- 4/A Open-market buy Director bought 500 shares at $7.30 ($3,650)
- 4 Open-market buy Director bought 3,650 shares at $7.30 ($26,645)
- 4 Open-market buy Chief Financial Officer bought 1,000 shares at $8.50 ($8,500)
- 4 Open-market buy Director bought 79,410 shares at $8.50 ($674,985)
- 4 Open-market buy President & CEO bought 23,529 shares at $8.50 ($199,997)
- 4 Open-market buy Director bought 5,000 shares at $8.50 ($42,500)
- 4 Open-market buy 10% owner bought 411,765 shares at $8.50 ($3,500,003)
- 4 Open-market buy 10% owner bought 308,824 shares at $8.50 ($2,625,004)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 17 of 19 · 364 filings